CID 139596833

8a-hydroxy avermectin b1a

Structural Information

Molecular Formula
C48H74O15
SMILES
CC[C@H](C)[C@@H]1[C@H](C=C[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\C(OC5[C@@]4([C@@H](CC(C5O)C)C(=O)O3)O)O)C)OC6C[C@@H]([C@H]([C@@H](O6)C)OC7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C
InChI
InChI=1S/C48H74O15/c1-11-24(2)42-27(5)17-18-47(63-42)23-32-20-31(62-47)16-15-26(4)41(59-38-22-36(55-10)43(30(8)57-38)60-37-21-35(54-9)40(50)29(7)56-37)25(3)13-12-14-33-45(51)61-44-39(49)28(6)19-34(46(52)58-32)48(33,44)53/h12-15,17-18,24-25,27-32,34-45,49-51,53H,11,16,19-23H2,1-10H3/b13-12+,26-15+,33-14+/t24-,25-,27-,28?,29-,30-,31+,32-,34-,35-,36-,37?,38?,39?,40-,41-,42+,43-,44?,45?,47+,48+/m0/s1
InChIKey
QTRXVXOQSMGGHD-UTSCHBFWSA-N
Compound name
(1'R,2R,3S,4'S,6S,8'R,10'E,12'S,13'S,14'E,16'Z,24'S)-2-[(2S)-butan-2-yl]-18',21',24'-trihydroxy-12'-[(4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-3,11',13',22'-tetramethylspiro[2,3-dihydropyran-6,6'-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16-triene]-2'-one
Related CIDs

2D Structure

compound 2d structure
4
Annotation Hits

0
References

0
Patents

890.50275 Da
Monoisotopic Mass

3.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 891.510026 297.7
[M+Na]+ 913.491968 299.1
[M-H]- 889.495474 293.6
[M+NH4]+ 908.536573 297.9
[M+K]+ 929.465908 292.0
[M+H-H2O]+ 873.500010 289.1
[M+HCOO]- 935.500951 298.5
[M+CH3COO]- 949.516601 301.0
[M+Na-2H]- 911.477416 319.2
[M]+ 890.50220142 306.4
[M]- 890.50329858 306.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.